SEQSTER Launches 1-Click Sites™ to Transform Clinical Sites into Research-Ready Data Collection Points

Names BioIVT as First Deployment Partner

Apr. 17, 2026 at 6:36am

Got story updates? Submit your updates here. ›

A highly detailed, glowing 3D illustration of a futuristic medical data processing hub, with neon cyan and magenta lights illuminating the intricate cybernetic infrastructure, conceptually representing the advanced technology powering the seamless flow of patient health data.SEQSTER's new 1-Click Sites™ technology aims to transform clinical research by enabling any site to quickly and securely share patient data, powering more efficient trials and personalized therapies.San Diego Today

SEQSTER, a leading healthcare technology company, has launched a new product called 1-Click Sites that enables clinical sites to seamlessly share patient-consented electronic health record (EHR) data with trial sponsors. The company also announced a partnership with BioIVT, a provider of human biological products for drug discovery and development, which will be the first to deploy the new product across its clinical sample collection network.

Why it matters

The new 1-Click Sites product from SEQSTER addresses a fundamental bottleneck in clinical research by removing the technical and operational barriers that have historically limited site participation. This allows any clinical site to quickly and cost-effectively contribute patient-consented data, expanding the pool of research-ready locations and enabling faster activation, broader reach, reduced screening failures, and access to richer longitudinal datasets for sponsors and CROs.

The details

1-Click Sites operates outside of a site's existing infrastructure, requiring no software installation, health system contracts, or disruption to clinical workflows. Pharmaceutical companies, CROs, and sample collection organizations can activate patient-consented data sharing at any site in a matter of days. Each site or network receives its own branded FDA 21 CFR Part 11-compliant study portal, and SEQSTER handles patient data aggregation, automated eligibility screening, and continuous monitoring throughout the study lifecycle.

  • SEQSTER and BioIVT will both be attending the American Association of Cancer Research (AACR) Annual Meeting 2026 in San Diego from April 17–22.

The players

SEQSTER PDM, Inc.

The leading healthcare technology company powering the connection, collection, and orchestration layer of patient health data.

BioIVT, LLC

The leading provider of human biological products for drug discovery and development.

Got photos? Submit your photos here. ›

What they’re saying

“Our partners look to us to deliver high-quality human samples that can support their research decisions. But those samples are only a fraction of the patient's story. What about the patient's medical history, the treatments they've received, and how they respond over time? This technology allows us to better track lab results and clinical outcomes before and after treatment to deliver deeper insights into how therapies perform in the real world. Together with SEQSTER, we look forward to empowering drug development with more complete, connected patient data that drives better, more informed decisions.”

— Jake Maxwell, Vice President, Corporate Development at BioIVT

“Life sciences companies have consistently asked us to make it easy to turn any clinical site into a data collection point. With 1-Click Sites, we've addressed a fundamental bottleneck in clinical research by removing the technical and operational barriers that have historically limited site participation. Now, any site can quickly and cost-effectively contribute patient-consented data, expanding the pool of research-ready locations. For sponsors and CROs, this means faster activation, broader reach, reduced screening failures through automated eligibility, and access to richer longitudinal datasets, ultimately enabling more efficient trials and accelerating the shift toward personalized research and care.”

— Ardy Arianpour, CEO and Co-Founder of SEQSTER

What’s next

SEQSTER and BioIVT will both be attending the American Association of Cancer Research (AACR) Annual Meeting 2026 in San Diego from April 17–22, where BioIVT will be exhibiting at Booth #4547 and showcasing SEQSTER's 1-Click Sites™.

The takeaway

The launch of SEQSTER's 1-Click Sites™ product represents a significant advancement in clinical research, as it removes the longstanding barriers that have limited site participation and access to comprehensive patient data. By enabling any clinical site to quickly and cost-effectively contribute patient-consented data, this technology has the potential to accelerate drug development and drive a shift toward more personalized, data-driven research and care.